Product Information for the Patient
Tadalafilo Mylan 5 mg Film-Coated Tablets
tadalafilo
Read this entire product information carefully before starting to take this medicine, as it contains important information for you.
Tadalafilo Mylan contains the active ingredient tadalafilo, which belongs to a group of medicines called phosphodiesterase type 5 inhibitors.
Tadalafilo Mylan 5 mg is used to treat adult men with:
Do not take Tadalafilo Mylan
Warnings and precautions
Consult your doctor before starting to take Tadalafilo Mylan.
Be aware that sexual activity can pose a possible risk for patients with heart problems, due to the additional strain it puts on the heart. If you have a heart problem, consult your doctor.
Since benign prostatic hyperplasia and prostate cancer can have the same symptoms, your doctor will perform a prostate cancer check before starting treatment with Tadalafilo Mylan for benign prostatic hyperplasia. Tadalafilo Mylan does not treat prostate cancer.
Before taking the tablets, inform your doctor if you have:
Tadalafilo Mylan is not known to be effective in patients who have undergone:
If you experience a decrease or sudden loss of vision, stop taking Tadalafilo Mylan and immediately contact your doctor.
There has been a perceived decrease or sudden loss of hearing in some patients using tadalafil. Although it is unknown if the event is directly related to tadalafil, if you experience a decrease or sudden loss of hearing, discontinue treatment with Tadalafilo Mylan and immediately contact your doctor.
Tadalafilo Mylan is not intended for use in women.
Children and adolescents
Tadalafilo Mylan should not be used in children or adolescents under 18 years old.
Other medicines and Tadalafilo Mylan
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medicine.
Do not take Tadalafilo Mylan if you are already taking nitrates.
Some medicines may be affected by Tadalafilo Mylan or may affect the proper functioning of Tadalafilo Mylan. Inform your doctor or pharmacist if you are using:
Taking Tadalafilo Mylan with beverages and alcohol
Orange juice may affect the proper functioning of Tadalafilo Mylan and should be taken with caution. Consult your doctor for more information.
Excessive alcohol consumption (blood alcohol level of 0.08% or higher) may increase the risk of dizziness when standing up. If you have taken or are planning to take Tadalafilo Mylan, avoid excessive alcohol consumption.
Fertility
In dogs treated, a decrease in sperm production by the testicles was observed. A decrease in sperm count has been observed in some men. It is unlikely that these effects will cause infertility.
Driving and operating machines
Some men who took Tadalafilo Mylan during clinical trials experienced dizziness. Check carefully how you react when taking the tablets before driving or operating machines.
Tadalafilo Mylan contains lactose
If your doctor has informed you that you have an intolerance to certain sugars, contact him before taking this medicine.
Tadalafilo Mylan contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor.
If in doubt, consult your doctor or pharmacist again.
For the treatment of erectile dysfunction
The recommended dose is one 5 mg tablet once a day, approximately at the same time. Your doctor may adjust the dose to 2.5 mg based on your response to Tadalafilo Mylan. This will be done by taking one 2.5 mg tablet.
Do not take Tadalafilo Mylan more than once a day.
Tadalafilo Mylan taken daily allows you to obtain an erection at any time during the 24 hours of the day, as long as there is sexual stimulation. A daily dose of Tadalafilo Mylan may be useful for men who expect to have sexual activity two or more times a week.
For the treatment of benign prostatic hyperplasia
The dose is one 5 mg tablet once a day, approximately at the same time. If you have benign prostatic hyperplasia and erectile dysfunction, the dose remains one 5 mg tablet once a day.
Do not take Tadalafilo Mylan more than once a day.
Tadalafilo Mylan tablets are for oral administration only in men. Swallow the tablet whole with a little water. Tablets can be taken with or without food.
If you take more Tadalafilo Mylan than you should
Consult your doctor. You may experience adverse effects described in section 4.
If you forgot to take Tadalafilo Mylan
Take your dose as soon as you remember, but do not take a double dose to make up for the missed dose. Do not take Tadalafilo Mylan more than once a day.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Tadalafilo Mylan can cause side effects, although not everyone will experience them. These side effects are generally mild to moderate in intensity.
If you experience any of the following side effects, stop using the medicine and seek medical help immediately:
Other side effects that have been reported:
Frequent(can affect up to 1 in 10 people)
Infrequent(can affect up to 1 in 100 people)
Rare(can affect up to 1 in 1000 people)
Infarction and stroke have also been reported rarely in men taking Tadalafilo Mylan. Most of these men had some heart problems before taking this medicine.
Rarely, cases of partial or permanent loss of vision in one or both eyes have been reported.
Some rare additional side effects have been reported in men taking Tadalafilo Mylan that were not reported during clinical trials. These include:
The most common side effect reported in men over 75 years old taking Tadalafilo Mylan was dizziness. Diarrhea cases were more frequently reported in patients over 65 years old taking Tadalafilo Mylan.
Reporting side effects
If you experience any type of side effect, consult yourdoctoror pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the national notification system included in theAppendix V.By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box after “CAD” and “EXP” respectively. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or trash. Ask your pharmacist how to dispose of the containers and medications that you no longer need. This will help protect the environment.
Composition of Tadalafilo Mylan
Core tablet: anhydrous lactose (see section 2 "Tadalafilo Mylan contains lactose"), poloxamer 188, microcrystalline cellulose (pH101), povidone (K-25), sodium croscarmellose, magnesium stearate, sodium lauryl sulfate, anhydrous colloidal silica.
Coating: lactose monohydrate, hypromellose (E464), titanium dioxide (E171), yellow iron oxide (E172), triacetin.
Appearance of the product and contents of the package
Tadalafilo Mylan 5 mg is a yellowish clear tablet, coated with a film, round, biconvex, marked with an "M" on one face and with "TL over 2" on the other face.
Tadalafilo Mylan 5 mg is available in blister packs containing 14, 28, 30, 56, 84, and 98 tablets.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Mylan S.A.S.
117 Allée des Parcs
69800 Saint-Priest
France
Responsible manufacturer
McDermott Laboratories Ltd. under the commercial name of Gerard Laboratories 35/36 Baldoyle Industrial Estate, Grange Road Dublin 13
Ireland
Mylan Hungary Kft.
Mylan utca 1
Komárom, 2900
Hungary
Generics [UK] Limited
Station Close
Potters Bar, EN6 1TL
United Kingdom
Mylan UK Healthcare Limited
Building 20, Station Close
Potters Bar, EN6 1TL
United Kingdom
Mylan Germany GmbH
Zweigniederlassung Bad Homburg v. d. Hoehe, Benzstrasse 1
Bad Homburg v. d. Hoehe
Hessen, 61352,
Germany
You can request more information about this medication by contacting the local representative of the marketing authorization holder.
België/Belgique/Belgien Mylan bvba/sprl Tél/Tel: + 32 (0)2 658 61 00 | Lietuva (Lithuania) BGP Products UAB Tel: + 370 5 205 1288 |
???????? (Bulgaria) ?????? ???? ???: + 359 2 44 55 400 | Luxembourg/Luxemburg Mylan bvba/sprl Tel: + 32 (0)2 658 61 00 (Belgique/Belgien) |
Ceská republika Mylan Healthcare CZ s.r.o. Tel: + 420 222 004 400 | Magyarország (Hungary) Mylan EPD Kft. Tel: + 36 1 465 2100 |
Danmark Mylan Denmark ApS Tel: + 45 28 11 69 32 | Malta V.J. Salomone Pharma Ltd Tel: + 356 21 22 01 74 |
Deutschland Mylan Healthcare GmbH Tel: + 49 800 0700 800 | Nederland Mylan BV Tel: + 31 (0)20 426 3300 |
Eesti (Estonia) BGP Products Switzerland GmbH Eesti filiaal Tel: + 372 6363 052 | Norge Mylan Healthcare Norge AS Tel: + 47 66 75 33 00 |
Ελλ?δα (Greece) Generics Pharma Hellas EPE Τηλ: + 30 210 993 6410 | Österreich Arcana Arzneimittel GmbH Tel: + 43 1 416 2418 |
España Mylan Pharmaceuticals, S.L. Tel: + 34 900 102 712 | Polska Mylan Healthcare Sp. z o.o. Tel: + 48 22 546 64 00 |
France Mylan S.A.S Tel: + 33 4 37 25 75 00 | Portugal Mylan, Lda. Tel: + 351 21 412 72 56 |
Hrvatska (Croatia) Mylan Hrvatska d.o.o. Tel: + 385 1 23 50 599 | România BGP Products SRL Tel: + 40 372 579 000 |
Ireland Mylan Ireland Limited Tel: + 353 (0) 87 1694982 | Slovenija Mylan Healthcare d.o.o. Tel: + 386 1 23 63 180 |
Ísland Icepharma hf Tel: + 354 540 8000 | Slovenská republika Mylan s.r.o. Tel: + 421 2 32 199 100 |
Italia Mylan Italia S.r.l. Tel: + 39 02 612 46921 | Suomi/Finland Mylan Finland OY Puh/Tel: + 358 20 720 9555 |
Κ?προς (Cyprus) Varnavas Hadjipanayis Ltd Tel: + 357 222 077 23 | Sverige Mylan AB Tel: + 46 855 522 750 |
Latvija Mylan Healthcare SIA Tel: + 371 676 05580 | United Kingdom Generics [U K] Ltd. Tel: + 44 1707 853000 |
Last review date of this leaflet:
Other sources of information
The detailed information about this medication is available on the website of the European Medicines Agency http://www.ema.europa.eu and on the website of the Spanish Agency of Medicines and Medical Products (AEMPS, http://www.aemps.gob.es/ )
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.